Navigation Links
Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets
Date:5/21/2014

Orlando, Fla., U.S., and Tokyo, Japan(May 21, 2014) Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases. The collaboration is built on an open-innovation model to bridge the gap between target discovery and pre-clinical drug development.

This collaboration focuses on identifying, validating, and screening novel drug targets, and studying new mechanisms of disease. The Sanford-Burnham team will identify and validate targets in collaboration with Cardiovascular-Metabolics Research Laboratories at Daiichi Sankyo. After the validation of the targets, collaboration teams will conduct drug screening to identify compounds that modulate the targets using facilities at both sites.

"The partnership will focus on the broad area of cardiovascular-metabolic diseases, which is a primary research area for Sanford-Burnham as well as a critical unmet medical need worldwide," said Dwight Towler, M.D., Ph.D., professor and director of the Cardiovascular Pathobiology Program at Sanford-Burnham. "Strategic partnerships such as this one serve as a key component of our Institute's 10-year vision to translate basic research discoveries into innovative therapies more quickly. Today's announcement represents another milestone for Sanford-Burnham as we connect our expertise in both basic research and drug discovery technology with pharmaceutical partners to implement this patient-oriented initiative."

"This is a unique and innovative early-stage drug discovery collaboration," said Dr. Masahiko Ohtsuki, Corporate Officer and Global Head of Research, Daiichi Sankyo. "The cardiovascular-metabolic area is a key priority for Daiichi Sankyo and we have found a strong, strategic partner in Sanford-Burnham. I am excited about this collaboration and look forward to seeing results of this partnership."


'/>"/>
Contact: Patrick Bartosch
pbartosch@sanfordburnham.org
407-745-2097
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Related biology news :

1. Sanford-Burnham presents cancer research at AACR
2. Sanford-Burnham receives US Air Force grant to perform next-generation toxicity screens
3. Sanford-Burnham Medical Research Institute and Mayo Clinic extend collaborative agreement
4. Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever
5. Sanford-Burnham and Intrexon Corporation establish collaboration to accelerate stem cell research
6. NIH New Innovator Award helps Sanford-Burnham scientist pursue high-risk, high-reward project
7. Californias stem cell agency boosts heart disease research at Sanford-Burnham
8. International patient alliance to fund Spanish Friedreichs ataxia gene-therapy project
9. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
10. Official opening of wildlife health genetic and forensic laboratory between EcoHealth Alliance and Sabah Wildlife Department
11. The China National Genebank accelerates growth by a strategic alliance with BioStorage Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/11/2016)... PUNE, India , March 11, 2016 ... to a new market research report "Image Recognition Market ... by Application (Marketing and Advertising), by Deployment Type (On-Premises ... Global Forecast To 2022", published by MarketsandMarkets, the global ... in 2015 to USD 29.98 Billion by 2020, at ...
Breaking Biology News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... biotechnology acceleration company reports the Company,s CEO  was ... capital titled Accelerators Enter When VCs Fear To ... Life Science Leader magazine is an ... work for everything from emerging biotechs to Big ...
(Date:4/28/2016)... ... April 28, 2016 , ... As part ... top industry experts, and expanding its LATAM network and logistics capabilities. Enhancements ... to manage their clinical trial projects. , The expansion will provide unmatched clinical ...
(Date:4/27/2016)... ... April 27, 2016 , ... Shimadzu Scientific Instruments ... Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to ... more. Expo attendees can stop by booth 1021 to learn how Shimadzu’s instruments ...
(Date:4/27/2016)... 2016 NanoStruck Technologies Inc. ... ( Frankfurt : 8NSK) gibt bekannt, ... 13. August 2015 die Genehmigung von der CNSX ... 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, um ... wurden 157.900.000 Einheiten mit dem ersten Teil der ...
Breaking Biology Technology: